Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-07 · accession 0001209191-22-002588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-07 | 2022-01-07 | ARWR | Ferrari Mauro | Dir | A - Grant | $0.00 | +6,400 | 43.0K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | A | A | 6,400 | $0.00 | 42,971 | D | — | — | (F1) Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. |